Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies:PROmics

Medicine & Life Sciences

1. Patient Reported Outcome Measures 100%
2. Cell- and Tissue-Based Therapy 32%
3. Feasibility Studies 31%
4. Systematic Reviews 22%
5. Clinical Trials 22%
6. Interviews 15%
7. Therapeutics 14%
8. Sclerosing Cholangitis 12%
9. Peer Review 12%
10. Patient Participation 11%
11. Nurses 10%
12. Research Ethics Committees 10%
13. Group Psychotherapy 10%
14. Ethics 10%
15. Congresses 9%
16. Informed Consent 9%
17. Neoplasms 9%
18. Crohn Disease 9%
19. Consensus 9%
20. Research Personnel 8%
21. Rheumatoid Arthritis 8%
22. Data Analysis 7%